XDH and hyperuricemia: Subsequently, the Effects of Xanthine Oxidase Inhibition on Hyperuricemic Heart Failure Patients (EXACT‐HF) study randomized patients (with primarily NYHA Class II and III HFrEF and hyperuricemia) to allopurinol (target dose 600 mg daily) versus placebo for 24 weeks.18